This GEMM recapitulates the stages of human breast tumor progression, including distant metastases, and expresses biomarkers that define human breast tumor subtypes, such as loss of estrogen and progesterone receptors and expression of ErbB2/HER2.44 This evidence concerns the gene PGR and breast neoplasm.